Editor-in-Chief
Paul Duprex
Center for Vaccine Research, University of Pittsburgh, PA, USA
Deputy Editor-in-Chief
Jo Parish
University of Birmingham, UK
Reviews Editor
Nicolas Locker Pirbright Institute, UK
Editors
Olivier Andreoletti Ecole Nationale Vétérinaire de Toulouse, France
Prion disease, Prion like disease, pathogenesis, neurodegeneration.
Dalan Bailey The Pirbright Institute, UK
Negative sense RNA viruses, paramyxoviruses, orthopneumoviruses, SARS-CoV-2, innate immunity, viral entry and exit, virus host-range, emerging pathogens, zoonoses, One Health.
Benjamin Brennan University of Glasgow, UK
Negative strand RNA viruses, bunyaviruses, Phenuiviridae, emerging viruses, reverse genetics, tick-borne viral disease, arboviruses, vaccines.
Sharon Brookes Animal and Plant Health Agency, Surrey, UK
Zoonotic and reverse zoonotic virology, one health focus, veterinary virology, animal models of human disease, zoonoses, reverse zoonoses virus transmission, host response – mammalian and avian, disease intervention – vaccine / antiviral efficacy testing, influenza.
Leen Delang KU Leuven, Flanders, Belgium
Antiviral drug discovery, arboviruses, virus transmission by mosquitoes, virus infection models in small animals.
Richard Kormelink Wageningen University, The Netherlands
Biotechnology, cellular biology, genetics, molecular biology, plant viruses, virology, pathology, disease resistance, molecular virology, nanotechnology, virus-host interactions, genetic engineering, Bunyaviridae, RNA silencing.
Dahai Luo Nanyang Technological University, Singapore
Replication process of positive-sense RNA viruses (arboviruses e.g. flaviviruses and alphaviruses), innate immune sensing of viral infection. Antiviral, RNA polymerase and replication, structural virology.
Matthew Reeves UCL, Institute of Immunity and Transplantation, London, UK
DNA viruses, herpes viruses, latency, epigenetic gene regulation, cell signalling, vaccination, anti-virals, innate and cell autonomous immunity.
Peter Revill Victorian Infectious Diseases Reference Laboratory, Royal Melbourne Hospital, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia
Molecular virology of hepatitis B virus (HBV), contribution of different HBV genotypes and variants to the striking differences in natural history, disease progression and global treatment responses.
Blair Strang University of London, UK
Human cytomegalovirus, herpes, DNA replication, DNA polymerase, protein-protein interaction, kinase, phosphorylation, intracellular signalling, drug discovery/development, high-throughput screening (chemical and genetic), vertical transmission, placental infection.
Manli Wang Wuhan Institute of Virology, China
Bunyaviruses; SARS-CoV-2; Baculovirus; Virus-host interaction; Viral pathogenesis and antiviral research, insect viruses, Arboviruses.
Christiane Wobus University of Michigan, Ann Arbor, USA
Caliciviruses, enteric viruses, astroviruses, virus–host/virus–bacteria interactions.
Murilo Zerbini Universidade Federal de Viçosa, Brazil
Geminivirus, begomovirus, variability, virus evolution, fitness, virus emergence, virus taxonomy.
Board of Reviewers
Evelien Adriaenssens Quadram Institute, UK
Bacteriophage, taxonomy, gut microbiome, viromics, viral community diversity, spread of pathogenic viruses.
Eduardo Bejarano University of Malaga – CSIC, Spain
Plant-virus interaction, DNA viruses.
Paul Britton The Pirbright Institute, UK
Nidoviruses, infectious bronchitis virus, positive sense RNA viruses.
Andrew Broadbent University of Maryland, USA
Molecular virology, double-stranded RNA viruses, segmented RNA viruses, viral pathogenesis, viral immunosuppression.
Colin Crump University of Cambridge, UK
Virus–cell interactions, virus assembly and egress, herpesviruses, polyomaviruses.
Juan Fontana University of Leeds, UK
Structural characterisation of macromolecular assemblies, viruses that are a current public health risk (like HIV, Influenza, herpesviruses and bunyaviruses), using cryo-EM, combined with other structural approaches.
Anthony Griffiths Boston University School of Medicine, MA, USA
BSL-4/CL4, high consequence pathogens, Ebola virus, Marburg virus, Lassa virus, Nipah virus, vaccine, therapeutic, animal models, non-human primate.
Mark Harris University of Leeds, UK
RNA viruses, particularly positive strand.
Amy Hartman Center for Vaccine Research, University of Pittsburgh, USA
Negative strand RNA viruses, emerging viruses, bunyaviruses, filoviruses, arenaviruses, Rift Valley fever, Ebola, neurotropic viruses, blood brain barrier, CNS infections, vector borne viruses (arboviruses), zoonotic viruses, vertical transmission, foetal infections, placental infections, animal models (rodents, ferrets, livestock, monkeys), aerosol exposure, vaccines.
Elisabeth Herniou Insect Biology Research Institute, UMR 7261, CNRS-Université de Tours, France
Insect viruses, phylogenetic, comparative genomics, viral diversity, Taxonomy, Baculoviridae, Polydnaviridae, Nudiviridae.
Edward Hutchinson University of Glasgow, UK
Influenza viruses, molecular biology, proteomics, RNA viruses.
Ryan Langlois University of Minnesota, USA
Antiviral immunity, influenza virus, virus host interactions, vaccination, virus transmission, virus evolution.
Chris McCormick University of Southampton, UK
Hepatitis C and related viruses, Norovirus, Hepacivirus, Flavivirus, Pestivirus, Pegivirus, Enterovirus.
Gerald McInerney Karolinska Institutet, Sweden
Virus-host interactions, alphaviruses, stress granules.
Eng Eong Ooi Duke NUS Medical School, Singapore
Dengue, other flaviviruses, host–pathogen interaction, immunity.
Viviana Parreno Instituto de Virologia, Instituto Nacional de Tecnologia Agropecuaria (INTA), Argentina
Viral enteric pathogens: Rotavirus, coronavirus, norovirus; Viral vaccines for bovines and horses: development vaccines and lab animal models for vaccine potency testing.
Andreas Pichlmair Technical University of Munich, Germany
Antiviral innate immunity, virus-host interactions, mass spectrometry.
Nicola Rose NIBSC, UK
Flaviviruses, hepaciviruses, rotavirus, retroviruses, models of acute and chronic viral infection and disease; pathogenesis, protection, host genetics and susceptibility, viral hepatitis, viral vaccines, flaviviruses, in vivo model systems, pathogenesis.
Silke Stertz University of Zurich, Switzerland
Influenza virus entry, RNAi screens for host factors required for replication, antivirals for influenza, virus host interactions, restriction factors for influenza viruses (Mx, IFITM etc.), Orthomyxovirus, host.
Mark Wills University of Cambridge, Addenbrooke's Hospital, UK
Herpesviruses, immunevasion, immunology, latency, T cells, NK cells, cytomegalovirus.
Murilo Zerbini Universidade Federal de Viçosa, Brazil
Ecology and evolution of plant DNA viruses, geminivirus, begomovirus, variability, virus evolution, fitness, virus emergence, virus taxonomy.
Sarah Caddy Baker Institute for Animal Health, Cornell University, USA
Virus-antibody interactions, and my lab currently works with rotaviruses, LCMV and influenza. Maternal and neonatal immunity of different species, and new vaccine developments.
Caroline Goujon IRIM, France
Intrinsic immunity, innate immunity, interferon, restriction factors, HIV-1, influenza A virus, SARS-CoV-2, CRISPR screens.
Theodora Hatziioannou The Rockefeller University, New York, USA
Retrovirology, HIV-1, restriction factors, animal models, virus entry.